Published in Am Pract Dig Treat on January 01, 1962
Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study. Ann Intern Med (1961) 12.08
The carrier state in viral hepatitis. J Am Med Assoc (1954) 3.96
Purification and immunological characterization of types 4 and 5 adenovirus-soluble antigens. Proc Natl Acad Sci U S A (1961) 3.65
The inhibitory effect of polysaccharide on mumps virus multiplication. J Exp Med (1948) 3.56
Some factors associated with the development of coronary heart disease: six years' follow-up experience in the Framingham study. Am J Public Health Nations Health (1959) 3.48
A skin test for infectious hepatitis. Proc Soc Exp Biol Med (1950) 3.13
Etiologic relationship of the RI-67 agent to acute respiratory disease (ARD). J Clin Invest (1955) 2.90
Sequential cellular changes produced by types 5 and 7 adenoviruses in HeLa cells and in human amniotic cells; cytological studies aided by fluorescein-labelled antibody. J Exp Med (1959) 2.73
Tryptose phosphate broth as supplementary factor for maintenance of HeLa cell tissue cultures. Proc Soc Exp Biol Med (1955) 2.69
Studies of acute respiratory illnesses caused by respiratory syncytial virus. 2. Epidemiology and assessment of importance. N Engl J Med (1961) 2.66
Clinical trials in infants of orally administered attenuated poliomyelitis viruses. Pediatrics (1959) 2.58
Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. IV. Final report of results based on clinical diagnoses. J Am Med Assoc (1953) 2.56
Cytological and cytochemical studies of HeLa cells infected with adeno-viruses. J Exp Med (1957) 2.44
Synthesis of virus-specific polymers in adenovirus-infected cells; effect of 5-fluorodeoxyuridine. J Exp Med (1962) 2.44
Quantitative aspects of the multiplication of influenza A virus in the mouse lung; relation between the degree of viral multiplication and the extent of pneumonia. J Exp Med (1952) 2.36
Human plasmapheresis and its effect on antibodies. J Immunol (1957) 2.35
Infectious hepatitis; length of protection by immune serum globulin (gamma globulin) during epidemics. J Am Med Assoc (1951) 2.29
Immunization of infants with living attenuated poliomyelitis virus; laboratory investigations of alimentary infection and antibody response in infants under six months of age with congenitally acquired antibodies. J Am Med Assoc (1956) 2.24
Pyridoxine dependency: report of a case of intractable convulsions in an infant controlled by pyridoxine. Pediatrics (1954) 2.17
The reaction of influenza viruses with guinea pig polymorphonuclear leucocytes. II. The reduction of white blood cell glycolysis by influenza viruses and receptor-destroying enzyme (RDE). Virology (1956) 2.17
Studies of acute respiratory illnesses caused by respiratory syncytial virus. 3. Clinical and laboratory findings. N Engl J Med (1961) 2.11
Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. 3. Preliminary report of results based on clinical diagnosis. J Am Med Assoc (1952) 2.11
A SHORT DESCRIPTION OF THE ADENOVIRUS GROUP. Virology (1963) 2.09
Identification of poliovirus particles of different antigenicity by specific agglutination as seen in the electron microscope. Virology (1962) 2.00
A labile component of normal serum which combines with various viruses; neutralization of infectivity and inhibition of hemagglutination by the component. J Exp Med (1949) 1.98
Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. 2. Conduct and early follow-up of 1952 Texas and Iowa-Nebraska studies. J Am Med Assoc (1952) 1.93
Acute respiratory illnesses among children and adults. Field study of contemporary importance of several viruses and appraisal of the literature. JAMA (1962) 1.92
Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. I. Plan of controlled field tests and results of 1951 pilot study in Utah. J Am Med Assoc (1952) 1.90
Immunohistochemical studies on the interaction between Ehrlich ascites tumor cells and Newcastle disease virus. J Exp Med (1957) 1.85
STRUCTURE OF TYPE 5 ADENOVIRUS. II. FINE STRUCTURE OF VIRUS SUBUNITIS. MORPHOLOGIC RELATIONSHIP OF STRUCTURAL SUBUNITS TO VIRUS-SPECIFIC SOLUBLE ANTIGENS FROM INFECTED CELLS. J Exp Med (1963) 1.83
Characteristics on the adenoviruses. III. Reproductive cycle of types 1 to 4. J Exp Med (1958) 1.79
A toxin-like material separable from type 5 adenovirus particles. Virology (1958) 1.79
Characteristics of the multiplication cycle of pneumonia virus of mice (PVM). J Exp Med (1951) 1.77
The dependence of the pathological lesion upon the multiplication of pneumonia virus of mice (PVM); kinetic relation between the degree of viral multiplication and the extent of pneumonia. J Exp Med (1951) 1.77
Endemic infectious hepatitis in an infants' orphanage. I. Epidemiologic studies in student nurses. AMA Arch Intern Med (1952) 1.76
An improved CO2 cabinet for low temperature storage of infectious agents with gaseous CO2 excluded from the specimen compartment. J Bacteriol (1951) 1.76
Nucleuc acid synthesis in types 4 and 5 adenovirus-infected HeLa cells. J Exp Med (1961) 1.75
A resistant variant of mumps virus; multiplication of the variant in the presence of inhibitory quantities of Friedländer bacillus polysaccharide. J Exp Med (1949) 1.74
Epidemiology of viral hepatitis A. Am J Public Health Nations Health (1953) 1.72
SUDDEN AND UNEXPECTED DEATH IN INFANTS. II. VIRAL INFECTIONS AS CAUSATIVE FACTORS. J Pediatr (1963) 1.72
Therapy of infection with pneumonia virus of mice (PVM); effect of a polysaccharide on the multiplication cycles of the virus and on the course of the viral pneumonia. J Exp Med (1951) 1.72
PRODUCTION OF SPECIFIC NEUTRALIZING ANTIBODY WITH SOLUBLE ANTIGENS OF TYPE 5 ADENOVIRUS. Proc Soc Exp Biol Med (1963) 1.72
STRUCTURE OF TYPE 5 ADENOVIRUS. I. ANTIGENIC RELATIONSHIP OF VIRUS-STRUCTURAL PROTEINS TO VIRUS-SPECIFIC SOLUBLE ANTIGENS FROM INFECTED CELLS. J Exp Med (1963) 1.69
THE ENTRY AND DISTRIBUTION OF HERPES VIRUS AND COLLOIDAL GOLD IN HELA CELLS AFTER CONTACT IN SUSPENSION. J Exp Med (1964) 1.67
Identification and classification of adenoviruses. Virology (1962) 1.63
Use of living attenuated measles-virus vaccine in early infancy. N Engl J Med (1960) 1.62
Infections due to group B beta-hemolytic streptococci. Report of three cases and review of the literature. N Engl J Med (1962) 1.60
Living attenuated measles-virus vaccine in early infancy. Studies of the role of passive antibody in immunization. N Engl J Med (1961) 1.60
Mechanism of production of pulmonary lesions in mice by Newcastle disease virus (NDV). J Exp Med (1951) 1.59
CYTOPATHOGENIC MYCOPLASMAS ASSOCIATED WITH TWO HUMAN TUMORS. II. MORPHOLOGICAL ASPECTS. J Bacteriol (1965) 1.59
Relation of the new respiratory agents to acute respiratory diseases. Am J Public Health Nations Health (1955) 1.58
Deoxyribonucleic acid (DNA) and protein alterations in HeLa cells infected with type 4 adenovirus. J Exp Med (1959) 1.57
Evidence for the specific etiology of acute respiratory disease (ARD). Trans Assoc Am Physicians (1954) 1.57
The effect of polysaccharides on the reaction between erythrocytes and viruses, with particular reference to mumps virus. J Exp Med (1948) 1.56
The significance of the viral carrier state in tissue culture systems. Prog Med Virol (1958) 1.54
Epidemiology of infectious hepatitis and problems of prevention and control. J Am Med Assoc (1952) 1.54
Protein synthesis in type 5 adenovirus-infected cells. Effect of p-flourophenylalanine on synthesis of protein. nucleic acids, and infectious virus. Virology (1963) 1.50
Characteristics of the new respiratory viruses (adenoviruses). I. Qualitative and quantitative aspects of the neutralization reaction. J Immunol (1956) 1.48
Studies on the complement fixing antigens of poliomyelitis. I. Demonstration of type and group specific antigens in native and heated viral preparations. J Immunol (1958) 1.44
Studies of acute respiratory illnesses caused by respiratory syncytial virus. 1. Laboratory findings in 109 cases. Proc Soc Exp Biol Med (1961) 1.43
Observations on the concentrating and diluting mechanisms of the diseased kidney. J Clin Invest (1959) 1.43
Studies on the agent of infectious hepatitis; propagation of the agent in tissue culture and in the embryonated hen's egg. J Exp Med (1950) 1.40
Elimination of nonspecific components from viral antigens by fluorocarbon. J Immunol (1958) 1.36
Encephalomyelitis due to infection with Herpesvirus simiae (herpes B virus); a report of two fatal, laboratory-acquired cases. N Engl J Med (1959) 1.34
A study of illness in a group of Cleveland families. X. The occurrence of adenovirus infections. Am J Hyg (1956) 1.32
Persistent immunity following Enders live, attenuated measles-virus vaccine given with human immune globulin. N Engl J Med (1962) 1.31
Biological and biochemical basis for cell injury by animal viruses. Fed Proc (1961) 1.30
Studies on the agent of infectious hepatitis; the disease produced in human volunteers by the agent cultivated in tissue culture or embryonated hen's eggs. J Exp Med (1950) 1.29
The persistence in the human circulation of horse and human tetanus antitoxins. J Pediatr (1961) 1.29
Suppression of influenza viral pneumonia in mice by the non-specific action of xerosin. J Immunol (1955) 1.27
Concurrent infection with influenza virus and mumps virus or pneumonia virus of mice as bearing on the inhibition of virus multiplication by bacterial polysaccharides. J Exp Med (1949) 1.27
Reactions of influenza viruses with guinea pig polymorphonuclear leucocytes. I. Virus-cell interactions. Virology (1956) 1.26
Ender's live measles-virus vaccine with human immune globulin. II. Evaluation of efficacy. Am J Dis Child (1962) 1.25
Characteristics of the new respiratory viruses (adenoviruses). II. Stability to temperature and pH alterations. Proc Soc Exp Biol Med (1956) 1.24
Viral hepatitis in the newborn; clinical features, epidemiology, and pathology. AMA Am J Dis Child (1951) 1.24
Clinical and laboratory findings in cases of respiratory illness caused by coryzaviruses. Ann Intern Med (1962) 1.20
EPIDEMIOLOGIC INVESTIGATIONS OF RHINOVIRUS INFECTIONS. Proc Soc Exp Biol Med (1964) 1.19
Herpangina; clinical and laboratory aspects of an outbreak caused by group A Coxsackie viruses. Pediatrics (1953) 1.19
Endemic infectious hepatitis in an infants' orphanage. II. Epidemiologic studies in infants and small children. AMA Arch Intern Med (1952) 1.18
ULTRASTRUCTURE OF A MYCOPLASMA (NEGRONI) ISOLATED FROM HUMAN LEUKEMIA. J Bacteriol (1965) 1.16
The properdin system and immunity. VI. The inactivation of Newcastle disease virus by the properdin system. J Exp Med (1956) 1.16
Studies on the complement-fixing antigens of poliomyelitis. III. Intracellular development of antigen. J Immunol (1961) 1.15
The reaction of influenza viruses with guinea pig polymorphonuclear leucocytes. III. Studies on the mechanism by which influenza viruses inhibit phagocytosis. Virology (1956) 1.14
Intracellular localization of type 4 adenovirus. II. Cytological and fluorescein-labelled antibody studies. J Exp Med (1959) 1.14
Studies on the use of aureomycin in hepatic disease. III. A note on aureomycin therapy in hepatic coma. Am J Med Sci (1950) 1.13
The silent coronary: the frequency and clinical characteristics of unrecognized myocardial infarction in the Framingham study. Ann Intern Med (1959) 1.12
Dissociation of poliomyelitis virus from neutralizing antibody. Virology (1958) 1.10
The control of viral hepatitis. Am J Med (1962) 1.09
Failure of convalescent gamma globulin to protect against homologous serum hepatitis. J Am Med Assoc (1953) 1.09
Studies on the routine laboratory diagnosis of coxsackie group B virus infections. I. The application of tissue culture procedures. J Lab Clin Med (1957) 1.05
Antimicrobial agents in the prevention of dietary hepatic injury (necrosis, cirrhosis) in rats. J Exp Med (1951) 1.05
B virus infection in man. Ann N Y Acad Sci (1960) 1.05
Inactivation of several viruses by liquid ethylene oxide. Proc Soc Exp Biol Med (1950) 1.03
Studies on the use of aureomycin in hepatic disease. II. The effect of aureomycin on experimental dietary hepatic necrosis. Am J Med Sci (1950) 1.02
Immunization of children by the feeling of living attenuated Type I and Type II poliomyelitis virus and the intramuscular injection of immune serum globulin. Am J Med Sci (1956) 1.02
Relationship between viral RNA and viral protein synthesis. Virology (1962) 1.02
A prolonged outbreak of infectious hepatitis in nurses due to a group of small children serving as a reservoir of the virus. J Clin Invest (1950) 1.01
Immunologic studies of measles. Am J Hyg (1961) 1.00
Aseptic meningitis caused by Coxsackie virus with isolation of virus from cerebrospinal fluid. J Am Med Assoc (1954) 0.99